TAP II Device and Online Platform Usability
Research type
Research Study
Full title
Usability Evaluation of TAP II Device and Seventh Sense Online Platform
IRAS ID
303691
Contact name
Richard Williams
Contact email
Sponsor organisation
Seventh Sense BioSystems
Duration of Study in the UK
0 years, 5 months, 4 days
Research summary
Up to N=230 in-home-use-tests with participants in the UK with an at-home blood collection device called the TAP II. This device is marked with CE approval by the MHRA. The company that developed this device, Seventh Sense Biosystems, is now looking to do research on the online platform they are developing to go with the device. This platform would allow users to create an account, order a blood draw kit to their home, conduct a blood draw, and then return the blood sample for processing using the provided shipping materials. Participants of this study will be asked to use parts of the platform that are developed, conduct a blood draw with the device, and take short (<5-minute) surveys throughout their experience.
REC name
North East - Newcastle & North Tyneside 2 Research Ethics Committee
REC reference
21/NE/0155
Date of REC Opinion
16 Aug 2021
REC opinion
Further Information Favourable Opinion